Details for New Drug Application (NDA): 202634
✉ Email this page to a colleague
NDA 202634 describes CAPREOMYCIN SULFATE, which is a drug marketed by Hisun Pharm Hangzhou and Pharmobedient and is included in two NDAs. Additional details are available on the CAPREOMYCIN SULFATE profile page.
The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the capreomycin sulfate profile page.
The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the capreomycin sulfate profile page.
Summary for 202634
| Tradename: | CAPREOMYCIN SULFATE |
| Applicant: | Pharmobedient |
| Ingredient: | capreomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202634
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Nov 27, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
